Mutations in the KCNJ2 gene account for only 50% of patients with a classic triad of symptoms: ventricular tachycardia and QTc prolongation, characteristic craniofacial abnormalities, and periodic skeletal muscular weakness [19]. This evidence concerns the gene KCNJ2 and ventricular tachycardia.